Better health.
Within reach.
Every day.

Hikma launches Diazepam Injection, USP in the US

Good momentum across all businesses and updated Generics guidance

Hikma launches Regadenoson Injection in prefilled syringe

Watch Said Darwazah, Executive Chairman and Chief Executive Officer discuss our 2022 financial results

Meet Kimberly Lembo, Associate Director, Contract Lifecycle Management and Systems, US and discover why she loves working at Hikma!

#OwnYourCareer@Hikma

Meet Alexander Liang, Trade Operations, US and discover why he loves working at Hikma!

Read the latest blog post by Lana Ghanem, Managing Director, Hikma Ventures and Vice President, Digital Health Investments & Partnerships - Investing in the disruptive future of the pharmaceutical industry.

Read the latest blog post by Riad Mishlawi, President, Hikma Injectables on Hikma’s world class Injectables capabilities - bringing access to critical medicines.

Join us in helping to put better health within reach for millions of people

Our 2022 Sustainability Report

Our 2022 Annual Report